These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36138105)

  • 1. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.
    Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ
    J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Involvement in Patients with Chronic Kidney Disease.
    Bhattacharya A; Rana K; Vanpariya N; Roy R; Radadiya T; Singh S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives.
    Dobre MA; Ahlawat S; Schelling JR
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):203-211. PubMed ID: 38193308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects.
    Asp AM; Wallquist C; Rickenlund A; Hylander B; Jacobson SH; Caidahl K; Eriksson MJ
    Clin Physiol Funct Imaging; 2015 May; 35(3):223-30. PubMed ID: 24750894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic Indices in Pediatric Chronic Kidney Disease.
    ESfandiar N; Alaei M; Alaei F; Vahidshahi K; Javdani Yecta S
    Iran J Kidney Dis; 2022 Mar; 16(2):88-95. PubMed ID: 35489077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
    Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
    Fu X; Ren H; Xie J; Wang W; Li Y; Gao P; Chen N
    JAMA Netw Open; 2022 May; 5(5):e2214460. PubMed ID: 35616936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
    Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study.
    Babua C; Kalyesubula R; Okello E; Kakande B; Sebatta E; Mungoma M; Mondo C
    BMC Nephrol; 2015 Aug; 16():126. PubMed ID: 26238594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease.
    Peterson GE; de Backer T; Contreras G; Wang X; Kendrick C; Greene T; Appel LJ; Randall OS; Lea J; Smogorzewski M; Vagaonescu T; Phillips RA;
    Hypertension; 2013 Sep; 62(3):518-25. PubMed ID: 23836799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
    Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac metabolic remodelling in chronic kidney disease.
    Patel N; Yaqoob MM; Aksentijevic D
    Nat Rev Nephrol; 2022 Aug; 18(8):524-537. PubMed ID: 35637381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.